Floatz logo

TJ271

First-line Non-small-cell Lung Cancer

TJ Biopharma Co., Ltd.Phase 2
Rating in progress

TJ271 in First-line Non-small-cell Lung Cancer is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active